Restoration of biochemical function of the peroxisome in the temperature-sensitive mild forms of peroxisome biogenesis disorder in humans

Brain and Development

Volumn 22, Issue 1, 2000, Pages 8-12

  Imamura, Atsushi ^a,b   Shimozawa, Nobuyuki ^a   Suzuki, Yasuyuki ^a   Zhang, Zhongyi ^a   Tsukamoto, Toshiro ^b   Fujiki, Yukio ^c   Orii, Tadao ^d   Osumi, Takashi ^b   Kondo, Naomi ^a  

^a GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF HYOGO   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

^d CHUBU GAKUIN UNIVERSITY   (Japan)

Author keywords

Beta oxidation; Dihydroxyacetonephosphate acyltransferase activity; Infantile Refsum disease; Neonatal adrenoleukodystrophy; Peroxisome biogenesis disorders; Temperature sensitivity; Zellweger syndrome

Indexed keywords

ACYL COENZYME A OXIDASE; CATALASE; DIHYDROXYACETONE PHOSPHATE ACYLTRANSFERASE; MEMBRANE PROTEIN;

ADRENOLEUKODYSTROPHY; ARTICLE; BIOGENESIS; CELL CULTURE; CELL LINE; CONTROLLED STUDY; DISORDERS OF PEROXISOMAL FUNCTIONS; ENZYME ACTIVITY; HEAT SENSITIVITY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IN VITRO STUDY; LIPID OXIDATION; PEROXISOME; PHENOTYPE; REFSUM DISEASE; SKIN FIBROBLAST; ZELLWEGER SYNDROME;

ANIMALS; CELL CULTURE TECHNIQUES; FIBROBLASTS; HUMANS; PEROXISOMAL DISORDERS; PEROXISOMES; RECOVERY OF FUNCTION; TEMPERATURE;

EID: 0033955193     PISSN: 03877604     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0387-7604(99)00072-8     Document Type: Article

References (28)

1. Moser A.B., Rasmussen M., Naidu S., Watkins P.A., McGuniness M., Hajra A.K., et al. Phenotype of patients with peroxisomal disorders subdivided into sixteen complementation groups. J Pediatr. 127:1995;13-22.
2. Poulos A., Chiristodoulou J., Chow C.W., Goldblatt J., Paton B.C., Orii T., et al. Peroxisomal assembly defects: clinical, pathologic, and biochemical findings in two patients in a newly identified complementation group. J Pediatr. 127:1995;596-599.
3. Shimozawa N., Suzuki Y., Orii T., Moser A., Moser H.W., Wanders R.J. Standardization of complementation grouping of peroxisome-deficient disorders and the second Zellweger patient with peroxisomal assembly factor-1 (PAF-1) defect (letter). Am J Hum Genet. 52:1993;843-844.
4. Shimozawa N., Tsukamoto T., Suzuki Y., Orii T., Shirayoshi Y., Mori T., et al. A human gene responsible for Zellweger syndrome that affects peroxisome assembly. Science. 255:1992;1132-1134.
5. Dodt G., Braverman N., Wong C., Moser A., Moser H.W., Watkins P., et al. Mutations in the PTS1 receptor gene. PXR1, define complementation group 2 of the peroxisome biogenesis disorders. Nat Genet. 9:1995;115-125.
6. Wiemer E., Nuttley W.M., Bertolaet B.L., Li X., Francke U., Wheelock M.J., et al. Human peroxisomal targeting signal-1 receptor restores peroxisomal protein import in cells from patients with fatal peroxisomal disorders. J Cell Biol. 130:1995;51-65.
7. Fukuda S., Shimozawa N., Suzuki Y., Zhang Z., Tomatsu S., Tsukamoto T., et al. Human peroxisome assembly factor-2 (PAF-2): a gene responsible for group C peroxisome biogenesis disorder in humans. Am J Hum Genet. 59:1996;1210-1220.
8. Yahraus T., Braverman N., Dodt G., Kalish J.E., Morrell J.C., Moser H.W., et al. The peroxisome biogenesis disorder group 4 gene. PXAAA1, encodes a cytoplasmic ATPase required for stability of the PTS1 receptor. EMBO J. 15:1996;2914-2923.
9. Chang C.C., Lee W.H., Moser H.W., Valle D., Gould S.J. Isolation of the human PEX12 gene, mutated in group 3 of the peroxisome biogenesis disorders. Nat Genet. 15:1997;385-388.
10. Okumoto K., Shimozawa N., Kawai A., Tamura S., Tsukamoto T., Osumi T., et al. PEX12, the pathogenic gene of group III Zellweger syndrome: cDNA cloning by functional complementation on a CHO cell mutant, patient analysis, and characterization of PEX12p. Mol Cell Biol. 18:1998;4324-4336.
11. Reuber B.E., Germain-Lee E., Collins C.S., Morrell J.C., Ameritunga R., Moser H.W., et al. Mutations in PEX1 are the most common cause of peroxisome biogenesis disorders. Nat Genet. 17:1997;445-448.
12. Portsteffen H., Beyer A., Becker E., Epplen C., Pawlak A., Kunau W.H., et al. Human PEX1 is mutated in complementation group 1 of the peroxisome biogenesis disorders. Nat Genet. 17:1997;449-452.
13. Tamura S., Okumoto K., Toyama R., Shimozawa N., Tsukamoto T., Suzuki Y., et al. Human PEX1 cloned by functional complementation on a CHO cell mutant is responsible for peroxisome-deficient Zellweger syndrome of complementation group I. Proc Natl Acad Sci USA. 95:1998;4350-4355.
14. Warren D.S., Morrell J.C., Moser H.W., Valle D., Gould S.J. Identification of PEX10, the gene defective in complementation group 7 of the peroxisome-biogenesis disorders. Am J Hum Genet. 63:1998;347-359.
15. Okumoto K., Itoh R., Shimozawa N., Suzuki Y., Tamura S., Kondo N., et al. Mutation in PEX10 is the cause of Zellweger peroxisome deficiency syndrome of complementation group B. Hum Mol Genet. 7:1998;1399-1405.
16. Honsho M., Tamura S., Shimozawa N., Suzuki Y., Kondo N., Fujiki Y. Mutation in PEX16 is causal in the peroxisome-deficient Zellweger syndrome of complementation group D. Am J Hum Genet. 63:1998;1622-1630.
17. Imamura A., Tsukamoto T., Shimozawa N., Suzuki Y., Zhang Z., Fujiki Y., et al. Temperature-sensitive phenotype of peroxisome-assembly processes represent the milder forms of human peroxisome-biogenesis disorders. Am J Hum Genet. 62:1998;1539-1543.
18. Shimozawa N., Tsukamoto T., Suzuki Y., Orii T., Fujiki Y. Animal cell mutants represent two complementation groups of peroxisome-defective Zellweger syndrome. J Clin Invest. 90:1992;1864-1870.
19. Tsukamoto T., Yokota S., Fujiki Y. Isolation and characterization of Chinese hamster ovary cell mutants defective in assembly of peroxisomes. J Cell Biol. 110:1990;651-660.
20. Tsukamoto T., Miura S., Nakai T., Yokota S., Shimozawa N., Suzuki Y., et al. Peroxisome assembly factor-2, a putative ATPase cloned by functional complementation on a peroxisome-deficient mammalian cell mutant. Nat Genet. 11:1995;395-401.
21. Suzuki Y., Shimazawa N., Yajima S., Yamaguchi S., Orii T., Hashimoto T. Effects of sodium 2-[5-(4-chlorophenyl)pentyl]-oxirane-2-carboxylate (POCA) on fatty acid oxidation in fibroblasts from patients with peroxisomal diseases. Biochem Pharmacol. 41:1991;453-456.
22. Shimozawa N., Suzuki Y., Orii T., Yokota S., Hashimoto T. Biochemical and morphologic aspects of peroxisomes in the human rectal mucosa: diagnosis of Zellweger syndrome simplified by rectal biopsy. Pediatr Res. 24:1988;723-727.
23. Suzuki Y., Shimozawa N., Orii T., Igarashi N., Kono N., Hashimoto T. Molecular analysis of peroxisomal beta-oxidation enzymes in infants with Zellweger syndrome and Zellweger-like syndrome: further heterogeneity of the peroxisomal disorder. Clin Chim Acta. 172:1988;65-76.
24. Tsukamoto T., Shimozawa N., Fujiki Y. Peroxisome assembly factor 1: nonsense mutation in a peroxisome-deficient Chinese hamster ovary cell mutant and deletion analysis. Mol Cell Biol. 14:1994;5458-5465.
25. Imamura A., Tamura S., Shimozawa N., Suzuki Y., Zhang Z., Tsukamoto T., et al. Temperature-sensitive mutation in PEX1 moderates the phenotypes of peroxisome deficiency disorders. Hum Mol Genet. 7:1998;2089-2094.
26. Tsukamoto T., Miura S., Fujiki Y. Restoration by a 35K membrane protein of peroxisome assembly in a peroxisome-deficient mammalian cell mutant. Nature. 350:1991;77-81.
27. McKenna O., Arnold G., Holtzman E. Microperoxisome distribution in the central nervous system of the rat. Brain Res. 117:1976;181-194.
28. Giros M., Roels F., Prats J., Ruiz M., Ribes A., Espeel M., et al. Long survival in a case of peroxisomal biogenesis disorder with peroxisome mosaicism in the liver. Ann NY Acad Sci. 804:1996;747-749.